Concept Life Sciences has appointed Matilda Bingham as site director of its Alderley Park site in Cheshire, UK, and David Higton as principal scientist (biotransformation and metabolite identification), also based at the Alderley Park site.
Matilda has over 15 years’ experience in the pharmaceutical industry, in both biotech and pharma environments. She joins Concept from Redx Pharma, where she held positions as head of research and operations, and executive director of oncology and immunology.
David is a highly experienced scientist with a proven track record of delivering innovative, effective solutions. He has over 34 years of expertise in bioanalytical and biotransformation studies, including 23 years at Glaxo Group Research, now GlaxoSmithKline, where he supported pre-clinical, clinical, and discovery investigations, for both non-GLP and GLP studies. David joins Concept from Cyprotex, where he was most recently head of analytical sciences.